Last reviewed · How we verify
Placebo of Isosorbide Dinitrate — Competitive Intelligence Brief
marketed
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Isosorbide Dinitrate (Placebo of Isosorbide Dinitrate) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. This is a placebo formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Isosorbide Dinitrate TARGET | Placebo of Isosorbide Dinitrate | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Isosorbide Dinitrate CI watch — RSS
- Placebo of Isosorbide Dinitrate CI watch — Atom
- Placebo of Isosorbide Dinitrate CI watch — JSON
- Placebo of Isosorbide Dinitrate alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Isosorbide Dinitrate — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-isosorbide-dinitrate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab